Unlike older single-mechanism weight loss drugs, Retatrutide is engineered as a triagonist meaning it simultaneously activates three key metabolic receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
They may adjust your dosage or explore other therapies to suit your individual needs
The 30-Day GHK-Cu Injection Cycle: Loading Phase, Maintenance Phase, and What to Expect The GHK-Cu dosage protocol is divided into two 15-day phases within a 30-day active window, followed by a 30-day rest period before the next cycle begins
In the SURMOUNT-1 trial, participants on the highest dose lost an average of 22.4% of their body weight at 72 weeks numbers that approach what bariatric surgery achieves
Gut-Health Disruptors: Chronic stress alters gut flora within 24hrs, increasing inflammation and cortisol levels